Taiwan-based United Biomedical Inc. (UBI) Asia on Monday said it will file an appeal with the Taiwan Food and Drug Administration (FDA) after its request for emergency use authorization (EUA) for its COVID-19 vaccine was denied.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
-
Society
Cross-party lawmakers question eased migrant domestic worker rules
04/01/2026 08:38 PM -
Society
Lawmaker urges probe into FPCC over plastics supply crunch
04/01/2026 07:55 PM -
Society
Taiwan probes suspected damage to Matsu subsea cable by Chinese vessel
04/01/2026 07:27 PM -
Sports
Hsu Jo-hsi shines in first start for Japan's Fukuoka SoftBank Hawks
04/01/2026 07:01 PM -
Society
New Taipei to provide free school lunches; Taoyuan free textbooks
04/01/2026 06:45 PM